Articles

  • 4 days ago | thebignewsletter.com | Matt Stoller

    This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts

  • 4 days ago | thebignewsletter.com | Matt Stoller

    Welcome to BIG, a newsletter on the politics of monopoly power. If you’d like to sign up to receive issues over email, you can do so here. In late May, JP Morgan’s chief investment strategist Michael Cembalest went on the podcast Odd Lots, to discuss the stock market with co-hosts Joe Weisenthal and Tracy Alloway. He asked a question a lot of us have. Why haven’t the antitrust laws worked to constrain big tech, in particular Google?

  • 6 days ago | thebignewsletter.com | Matt Stoller

    This week’s monopoly round-up has a lot of useful news, as usual.

  • 1 week ago | thebignewsletter.com | Matt Stoller

    Welcome to BIG, a newsletter on the politics of monopoly power. If you’d like to sign up to receive issues over email, you can do so here. Two days ago, Oregon Governor Tina Kotek signed the nation’s strictest law against corporate control of health care practices in the state. It’s a major defeat for private equity and large health insurers, and something that advocates and physicians have been advocating for years, as more and more of the state’s capacity got bought up by financiers.

  • 1 week ago | thebignewsletter.com | Matt Stoller

    Today’s round-up has a lot of stuff. The war between Musk and Trump could lead to significant changes in personnel in the administration, the copyright office put out a potential fix for McDonald’s ice cream machines, and an appeals court refused to grant Apple’s emergency request to give it back its app store monopoly. Before going to that, I’m going to focus on something personal, which is my role as an American elite, because it intersects with a political fight that’s going on right now.

Contact details

No sites or socials found.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →